Chapter 7. The Pharmacoepidemiology of Psychiatric Medications

  1. Ming T. Tsuang2,3,
  2. Mauricio Tohen4,5
  1. Philip S. Wang1,
  2. Alexander M. Walker2,
  3. Jerry Avorn1

Published Online: 22 APR 2003

DOI: 10.1002/0471234311.ch7

Book Title

Textbook in Psychiatric Epidemiology, Second Edition

Textbook in Psychiatric Epidemiology, Second Edition

Additional Information

How to Cite

Wang, P. S., Walker, A. M. and Avorn, J. (2003) The Pharmacoepidemiology of Psychiatric Medications, in Textbook in Psychiatric Epidemiology, Second Edition (eds M. T. Tsuang and M. Tohen), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/0471234311.ch7

Editor Information

  1. 2

    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA

  2. 3

    Pediatric Psychopharmacology Unit, Psychiatry Service, Massachusetts General Hospital, Boston, MA 02115, USA

  3. 4

    Lilly Research Laboratories, Indianapolis, IN, USA

  4. 5

    Department of Psychiatry, McLean Hospital, Harvard Medical School, Boston, MA 02184, USA

Author Information

  1. 1

    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital Medical School, Boston, MA 02115, USA

  2. 2

    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA

Publication History

  1. Published Online: 22 APR 2003
  2. Published Print: 23 AUG 2002

ISBN Information

Print ISBN: 9780471409748

Online ISBN: 9780471234319

SEARCH

CHAPTER TOOLS

Get PDF (97K)

Keywords:

  • pharmacoepidemiology of psychiatric medications;
  • overview of psychopharmacoepidemiology;
  • sources of data;
  • specific clinical questions;
  • future directions

Summary

This chapter provides a brief overview of the field of psychiatric medications, potential data sources for investigators, examples of psychopharmacoepidemiologic studies, and some suggestions for future developments.

Get PDF (97K)